These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Letter: Thymoxamine and spasticity. White C; Richens A Lancet; 1974 Apr; 1(7859):686-7. PubMed ID: 4132359 [No Abstract] [Full Text] [Related]
3. Depression of spasticity by alpha-adrenergic blockade. Mai J Acta Neurol Scand; 1978 Jan; 57(1):65-76. PubMed ID: 147002 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of oral thymoxamine in patients with peripheral vascular occlusion of the lower limbs. Thomas M; Campbell H; Heard GE Br J Surg; 1973 Jul; 60(7):545-8. PubMed ID: 4268626 [No Abstract] [Full Text] [Related]
5. [C34.647-Ba (Lioresal) in the treatment of hypertonic manifestations of multiple sclerosis]. Ketelaer P; Tyberghein JM; Ketelaer CJ Brux Med; 1973 Nov; 53(11):675-81. PubMed ID: 4769203 [No Abstract] [Full Text] [Related]
7. Effect of thymoxamine in the relief of pain and rate of healing in ischaemic leg ulceration. Williamson DM; Gatecliff M Curr Med Res Opin; 1980; 6(7):500-1. PubMed ID: 6444863 [TBL] [Abstract][Full Text] [Related]
8. Letter: Treatment of spasticity in multiple sclerosis with dantrolene. Horne ML JAMA; 1976 Jan; 235(3):251. PubMed ID: 946040 [No Abstract] [Full Text] [Related]
9. Metabolism of 14C-moxisylyte in hairless rat. Comparison between intravenous and oral route. Neau B; Roux J; Lambrey B; Courtiol C; Marty JP; Grislain L Arzneimittelforschung; 1995 Jan; 45(1):10-4. PubMed ID: 7893260 [TBL] [Abstract][Full Text] [Related]
10. Thymoxamine: a miotic for intraocular use. Grehn F; Fleig T; Schwarzmüller E Graefes Arch Clin Exp Ophthalmol; 1986; 224(2):174-8. PubMed ID: 2936652 [TBL] [Abstract][Full Text] [Related]
11. Retrospective assessment of thymoxamine (Opilon) in treatment of Ménières disease. Young JR J Int Med Res; 1978; 6(2):166-8. PubMed ID: 147192 [TBL] [Abstract][Full Text] [Related]
13. The quantitative evaluation of intravenous methocarbamol in the relief of spasticity. Levine IM; Jossmann PB; Rudd J; De Angelis V Neurology; 1968 Jan; 18(1 Pt 1):69-74. PubMed ID: 4865709 [No Abstract] [Full Text] [Related]
14. Metabolism of 14C-moxisylyte after percutaneous application in hairless rat. Neau B; Roux J; Marty JP Arzneimittelforschung; 1998 Jan; 48(1):34-8. PubMed ID: 9522028 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat. Neau B; Roux J; Courtiol C; Lambrey B; Marty JP Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231 [TBL] [Abstract][Full Text] [Related]
16. Letter: Treatment of spasticity in multiple sclerosis with dantrolene. Tolosa ES; Soll RW; Loewenson RB JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254 [No Abstract] [Full Text] [Related]
17. Myotonic-like syndrome in multiple sclerosis. Weintraub MI; Megahed MS; Smith BH N Y State J Med; 1970 Mar; 70(5):677-9. PubMed ID: 5263956 [No Abstract] [Full Text] [Related]
18. The effects of thymoxamine on anterior chamber depth in human eyes. Susanna R; Drance SM; Schulzer M; Douglas GR Can J Ophthalmol; 1978 Oct; 13(4):250-1. PubMed ID: 154360 [TBL] [Abstract][Full Text] [Related]
19. Use of diazepam for the relief of spasticity in multiple sclerosis. Simpson CA Ann Phys Med; 1964; Suppl():39-40. PubMed ID: 5825182 [No Abstract] [Full Text] [Related]
20. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs]. Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884 [No Abstract] [Full Text] [Related] [Next] [New Search]